HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Schering-Plough

This article was originally published in The Rose Sheet

Executive Summary

Schering-Plough: Sun care product sales declined 1.5% to $129 mil. in 1994, while foot care product sales grew 3.3% to $248 mil. for the year, boosted by "sharp" fourth quarter sales of new corn/callus/bunion products and "higher" sales of insole lines, the company states. Healthcare products sales dropped 6% in 1994, due to lower OTC sales because of more competitive markets for vaginal antifungal and allergy/cold products, the company says. Consolidated sales rose 7.3% to $4.66 bil. in the year and were up 10.6% to $1.18 bil. in the quarter. Net income grew 26.2% to $922 mil. and 7.9% to $203.8 mil. in the 12 and three months, respectively...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001288

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel